Alert detail
LCD L38288: MolDX: Repeat Germline Testing — CGS
What changed
New LCD may impact repeat germline testing reimbursements.
Who’s affected: Oncology billing teams · Effective: January 22, 2026
Primary source: View the official CMS/MAC document ↗
Get the action steps and full analysis
This change affects 312 billing codes.
The full analysis, the revision comparison and the as-of-date version of this policy are what a partner packet carries. The source document above is free and always will be.